April 1 (Reuters) - British regulators on Thursday said they
have identified 30 cases of rare blood clot events after the use
of the AstraZeneca COVID-19 vaccine, 25 more than the agency
previously reported.
The Medicines and Healthcare products Regulatory Agency said
it had received no such reports of clotting events following use
of the vaccine made by BioNTech SE and Pfizer Inc
.
(Reporting By Peter Henderson and Julie Steenhuysen
Editing by Chris Reese)